What is Bristol-Myers Squibb's united states — property, plant and equipment?

Bristol-Myers Squibb (BMY) reported united states — property, plant and equipment of $4.93B in Q4 2025.

Geographic · Property, plant and equipment

United States — Property, plant and equipment

Bristol-Myers Squibb United States — Property, plant and equipment increased by 2.4% to $4.93B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $4.81B to $4.93B.

Analysis

StatementSegment

First reportedQ4 2017

Last reportedQ4 2025Feb 11, 2026

Rolls up toPP&E (Net)

Metric ID: bmy_segment_united_states_property_plant_and_equipment

Historical Data

5 periods

	Q4 '21	Q4 '22	Q4 '23	Q4 '24	Q4 '25
Value	$4.71B	$4.83B	$4.73B	$4.81B	$4.93B
QoQ Change	—	+2.6%	-2.1%	+1.8%	+2.4%
YoY Change	—	+2.6%	-2.1%	+1.8%	+2.4%

Range$4.71B – $4.93B

CAGR+4.7%

Avg YoY Growth+1.2%

Median YoY Growth+2.1%

Current Streak2 quarters growth

Frequently Asked Questions

What is Bristol-Myers Squibb's united states — property, plant and equipment?: Bristol-Myers Squibb (BMY) reported united states — property, plant and equipment of $4.93B in Q4 2025.
How has Bristol-Myers Squibb's united states — property, plant and equipment changed year-over-year?: Bristol-Myers Squibb's united states — property, plant and equipment increased by 2.4% year-over-year, from $4.81B to $4.93B.